{"gene":"PTAR1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2019,"finding":"PTAR1 forms a novel prenyltransferase complex (GGTase3) with the catalytic β-subunit of GGTase2 (RabGGTB). This complex specifically geranylgeranylates FBXL2, enabling its membrane localization where FBXL2 mediates polyubiquitylation of membrane-anchored proteins. Crystal structure of the full-length GGTase3-FBXL2-SKP1 complex reveals that an extensive multivalent interface between FBXL2's leucine-rich repeat domain and PTAR1 determines substrate specificity, despite FBXL2 having a CaaX motif predicted to be recognized by GGTase1.","method":"Co-IP, in vitro prenylation assay, crystal structure of GGTase3-FBXL2-SKP1 complex, cell membrane localization assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation, in vitro reconstitution of enzymatic activity, and multiple orthogonal methods in a single rigorous study","pmids":["31209342"],"is_preprint":false},{"year":2020,"finding":"PTAR1, together with the β-subunit of RabGGTase, constitutes GGTase-III, a novel prenyltransferase that geranylgeranylates the Golgi SNARE protein Ykt6 at Cys194 (the second prenylation, following prior farnesylation of Cys195 by FTase), generating a doubly prenylated Ykt6. In PTAR1-deficient cells, Ykt6 remains singly farnesylated, Golgi SNARE complex assembly is severely impaired, and the Golgi apparatus is structurally disorganized with delayed intra-Golgi protein trafficking. Crystal structure of GGTase-III in complex with Ykt6 provides the structural basis for double prenylation.","method":"Biotinylated geranylgeranyl analogue substrate identification, crystal structure of GGTase-III–Ykt6 complex, PTAR1 knockout cells with Golgi morphology and trafficking assays, SNARE complex assembly assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, reconstituted enzymatic activity with analogue labeling, and KO phenotypic validation using multiple orthogonal methods","pmids":["32128853"],"is_preprint":false},{"year":2021,"finding":"In PTAR1 KO cells where Ykt6 is only singly farnesylated (lacking GGTase-III-mediated geranylgeranylation), lysosomal hydrolases (cathepsin D and β-hexosaminidase) are missorted at the trans-Golgi network and secreted extracellularly, hydrolase maturation is disturbed, and LC3B accumulates indicating defective autophagy/lysosomal degradation pathways. This establishes that doubly prenylated Ykt6 (requiring PTAR1/GGTase-III) is required for efficient sorting and trafficking of acid hydrolases from Golgi to lysosomes.","method":"PTAR1 knockout cells, secretion assays for cathepsin D and β-hexosaminidase, Western blotting for hydrolase maturation, LC3B immunoblotting","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, multiple substrates assessed, single lab","pmids":["33035318"],"is_preprint":false},{"year":2025,"finding":"PTAR1 (α-subunit of GGTase-III) is expressed in human islets, mouse islets, and INS-1 832/13 pancreatic β-cells. siRNA-mediated knockdown of PTAR1 (~50% reduction) significantly attenuated glucose-stimulated insulin secretion (~60% reduction) and KCl-induced insulin secretion (~69% reduction), establishing a required role for GGTase-III-dependent signaling in insulin secretion.","method":"siRNA knockdown of PTAR1 in INS-1 832/13 cells, insulin ELISA, Western blotting","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single lab, siRNA knockdown with functional readout but no direct molecular mechanism beyond Ykt6 substrate connection; partial mechanistic follow-up","pmids":["40598917"],"is_preprint":false},{"year":2015,"finding":"Disruption of PTAR1 in haploid human cells led to resistance to Rift Valley fever virus infection and reduced heparan sulfate surface levels, consistent with PTAR1-deficient cells exhibiting altered Golgi complex morphology and glycosylation defects.","method":"Haploid genetic screen (insertional mutagenesis), flow cytometry for heparan sulfate levels, viral infection assays","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic screen with functional validation of Golgi/glycosylation phenotype, but mechanism is indirect (PTAR1 role in Golgi morphology/glycosylation inferred rather than directly dissected in this paper)","pmids":["26581979"],"is_preprint":false},{"year":2025,"finding":"A biotinylated geranylgeranyl analogue was used to confirm Ykt6 (at Cys194) as the direct substrate of GGTase-III (PTAR1/RabGGTB). Sequential prenylation: FTase farnesylates Cys195 first, then GGTase-III geranylgeranylates Cys194, producing doubly prenylated Ykt6 essential for Golgi maintenance and autophagosome clearance.","method":"Biotin-labeled geranyl pyrophosphate analogue in vitro prenylation assay, site-specific cysteine identification","journal":"Methods in molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic assay with analogue substrate, single lab, methodological/confirmatory paper replicating prior findings","pmids":["39806148"],"is_preprint":false}],"current_model":"PTAR1 is the α-subunit of GGTase-III (also called GGTase3), a novel prenyltransferase complex formed with RabGGTB (the β-subunit of RabGGTase), which geranylgeranylates specific substrates including the Golgi SNARE Ykt6 (at Cys194, producing doubly prenylated Ykt6 required for Golgi organization, lysosomal hydrolase trafficking, and autophagy) and the ubiquitin ligase FBXL2 (via an extensive LRR–PTAR1 interface that confers substrate specificity distinct from GGTase1); loss of PTAR1 disrupts Golgi morphology, glycosylation, lysosomal sorting, and glucose-stimulated insulin secretion."},"narrative":{"mechanistic_narrative":"PTAR1 is the α-subunit of GGTase-III (GGTase3), a prenyltransferase complex assembled with the catalytic β-subunit of RabGGTase (RabGGTB) that geranylgeranylates a small set of specific substrates and thereby governs Golgi organization and membrane trafficking [PMID:31209342, PMID:32128853]. One substrate is the Golgi SNARE Ykt6: GGTase-III geranylgeranylates Ykt6 at Cys194 following prior FTase-mediated farnesylation of Cys195, producing a doubly prenylated Ykt6, and crystal structures of the GGTase-III–Ykt6 complex define the structural basis for this second prenylation [PMID:32128853, PMID:39806148]. Loss of PTAR1 leaves Ykt6 only singly farnesylated, impairing Golgi SNARE complex assembly, disorganizing Golgi morphology, and delaying intra-Golgi trafficking [PMID:32128853]; downstream, lysosomal hydrolases such as cathepsin D and β-hexosaminidase are missorted and secreted, hydrolase maturation is disturbed, and LC3B accumulates, marking defective autophagy/lysosomal degradation [PMID:33035318]. The second characterized substrate is the F-box protein FBXL2: GGTase-III geranylgeranylates FBXL2 to drive its membrane localization, and the crystal structure of the GGTase3–FBXL2–SKP1 complex shows an extensive interface between FBXL2's leucine-rich-repeat domain and PTAR1 that dictates substrate specificity even though FBXL2's CaaX motif is predicted to be a GGTase1 substrate [PMID:31209342]. Consistent with its role in Golgi/glycosylation homeostasis, PTAR1 disruption alters Golgi morphology, lowers cell-surface heparan sulfate, and confers resistance to Rift Valley fever virus [PMID:26581979], and PTAR1 knockdown attenuates glucose- and KCl-stimulated insulin secretion in pancreatic β-cells [PMID:40598917].","teleology":[{"year":2015,"claim":"Before any enzymatic role was known, an unbiased genetic screen implicated PTAR1 in Golgi function by linking its loss to glycosylation defects and viral resistance.","evidence":"Haploid insertional-mutagenesis screen with heparan sulfate flow cytometry and Rift Valley fever virus infection assays","pmids":["26581979"],"confidence":"Medium","gaps":["Golgi/glycosylation phenotype was inferred, not mechanistically dissected","No enzymatic activity or substrate identified at this stage","Connection to a prenyltransferase complex not yet established"]},{"year":2019,"claim":"Established PTAR1 as the α-subunit of a novel prenyltransferase (GGTase3) by reconstituting its activity and solving its structure, answering what PTAR1 does biochemically and how it achieves substrate selectivity.","evidence":"Co-IP, in vitro prenylation assay, and crystal structure of the GGTase3–FBXL2–SKP1 complex with membrane-localization assays","pmids":["31209342"],"confidence":"High","gaps":["FBXL2 ubiquitylation targets downstream of membrane localization not enumerated here","Whether other LRR/CaaX proteins are substrates left open"]},{"year":2020,"claim":"Identified the Golgi SNARE Ykt6 as a GGTase-III substrate and showed PTAR1 catalyzes a second prenylation (Cys194 geranylgeranylation after Cys195 farnesylation), explaining how PTAR1 controls Golgi architecture.","evidence":"Biotinylated geranylgeranyl analogue substrate ID, GGTase-III–Ykt6 crystal structure, and PTAR1 KO Golgi morphology, trafficking, and SNARE assembly assays","pmids":["32128853"],"confidence":"High","gaps":["Did not extend to lysosomal/autophagy consequences","Full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2 unknown"]},{"year":2021,"claim":"Connected PTAR1/double-prenylated Ykt6 to lysosomal homeostasis by showing acid hydrolases are missorted and autophagy is impaired in its absence.","evidence":"PTAR1 KO cells with cathepsin D and β-hexosaminidase secretion assays, hydrolase maturation Westerns, and LC3B immunoblotting","pmids":["33035318"],"confidence":"Medium","gaps":["Single lab; mechanism downstream of Ykt6 prenylation not fully resolved","Direct causality versus general Golgi disruption not separated"]},{"year":2025,"claim":"Confirmed Ykt6 Cys194 as the direct GGTase-III substrate and established the sequential FTase-then-GGTase-III prenylation order using analogue labeling.","evidence":"Biotin-labeled geranyl pyrophosphate analogue in vitro prenylation with site-specific cysteine identification","pmids":["39806148"],"confidence":"Medium","gaps":["Methodological/confirmatory; no new substrates","Single lab"]},{"year":2025,"claim":"Extended PTAR1 function to physiology by showing GGTase-III is required for glucose-stimulated insulin secretion in β-cells.","evidence":"siRNA knockdown of PTAR1 in INS-1 832/13 cells with insulin ELISA and Western blotting","pmids":["40598917"],"confidence":"Medium","gaps":["Partial (~50%) knockdown; no rescue","Molecular mechanism linking GGTase-III to secretion beyond the Ykt6 connection not defined","In vivo relevance untested"]},{"year":null,"claim":"The full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2, and the precise mechanistic link between GGTase-III activity and insulin secretion, remain to be defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No comprehensive substrate census reported","Mechanism connecting PTAR1 to β-cell secretion undefined","No in vivo / disease-mutation evidence in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,4]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[2]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1]}],"complexes":["GGTase-III (GGTase3)"],"partners":["RABGGTB","YKT6","FBXL2","SKP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q7Z6K3","full_name":"Protein prenyltransferase alpha subunit repeat-containing protein 1","aliases":[],"length_aa":402,"mass_kda":46.4,"function":"Substrate-recognition subunit of the geranylgeranyl transferase type 3 (GGTase-3) complex (PubMed:31209342, PubMed:32128853). The GGTase-3 complex geranylgeranylates and targets FBXL2 to the cellular membranes, where FBXL2 forms part of the E3 ubiquitin-protein ligase complex SCF(FBXL2) that mediates the degradation of membrane-anchored proteins (PubMed:31209342, PubMed:32128853). The GGTase-3 complex geranylgeranylates Golgi v-SNARE protein YKT6 at 'Cys-194' and this prenylation is required for Golgi SNARE complex assembly (PubMed:32128853)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q7Z6K3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PTAR1","classification":"Not Classified","n_dependent_lines":337,"n_total_lines":1208,"dependency_fraction":0.27897350993377484},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RABGGTB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PTAR1","total_profiled":1310},"omim":[{"mim_id":"621024","title":"PROTEIN PRENYLTRANSFERASE ALPHA SUBUNIT REPEAT-CONTAINING PROTEIN 1; PTAR1","url":"https://www.omim.org/entry/621024"},{"mim_id":"614444","title":"RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1; RALGPS1","url":"https://www.omim.org/entry/614444"},{"mim_id":"606209","title":"YKT6 v-SNARE HOMOLOG; YKT6","url":"https://www.omim.org/entry/606209"},{"mim_id":"605652","title":"F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2","url":"https://www.omim.org/entry/605652"},{"mim_id":"179080","title":"RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB","url":"https://www.omim.org/entry/179080"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PTAR1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q7Z6K3","domains":[{"cath_id":"-","chopping":"2-99","consensus_level":"medium","plddt":95.1051,"start":2,"end":99},{"cath_id":"-","chopping":"126-155_172-211","consensus_level":"medium","plddt":95.5233,"start":126,"end":211},{"cath_id":"1.25.40","chopping":"216-256_288-331_359-402","consensus_level":"medium","plddt":89.1166,"start":216,"end":402}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z6K3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z6K3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z6K3-F1-predicted_aligned_error_v6.png","plddt_mean":83.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PTAR1","jax_strain_url":"https://www.jax.org/strain/search?query=PTAR1"},"sequence":{"accession":"Q7Z6K3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z6K3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z6K3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z6K3"}},"corpus_meta":[{"pmid":"31209342","id":"PMC_31209342","title":"GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase.","date":"2019","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31209342","citation_count":97,"is_preprint":false},{"pmid":"26581979","id":"PMC_26581979","title":"A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26581979","citation_count":97,"is_preprint":false},{"pmid":"32128853","id":"PMC_32128853","title":"A SNARE geranylgeranyltransferase essential for the organization of the Golgi apparatus.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/32128853","citation_count":71,"is_preprint":false},{"pmid":"33035318","id":"PMC_33035318","title":"Double prenylation of SNARE protein Ykt6 is required for lysosomal hydrolase trafficking.","date":"2021","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33035318","citation_count":19,"is_preprint":false},{"pmid":"39762849","id":"PMC_39762849","title":"Identification of macrophage polarisation and mitochondria-related biomarkers in diabetic retinopathy.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39762849","citation_count":11,"is_preprint":false},{"pmid":"39806148","id":"PMC_39806148","title":"Use of Biotin-Labeled Geranyl Pyrophosphate for Analysis of Ykt6 Geranylgeranylation.","date":"2025","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/39806148","citation_count":2,"is_preprint":false},{"pmid":"40598917","id":"PMC_40598917","title":"Novel Roles for Geranylgeranyl Transferase-III (GGTase-III) in Insulin Secretion.","date":"2025","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40598917","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.03.680283","title":"Identification of key host genes for influenza A virus in avian cells using a genome-wide CRISPR-Cas9 screen","date":"2025-10-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.03.680283","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6654,"output_tokens":1967,"usd":0.024733,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8846,"output_tokens":2681,"usd":0.055628,"stage2_stop_reason":"end_turn"},"total_usd":0.080361,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"PTAR1 forms a novel prenyltransferase complex (GGTase3) with the catalytic β-subunit of GGTase2 (RabGGTB). This complex specifically geranylgeranylates FBXL2, enabling its membrane localization where FBXL2 mediates polyubiquitylation of membrane-anchored proteins. Crystal structure of the full-length GGTase3-FBXL2-SKP1 complex reveals that an extensive multivalent interface between FBXL2's leucine-rich repeat domain and PTAR1 determines substrate specificity, despite FBXL2 having a CaaX motif predicted to be recognized by GGTase1.\",\n      \"method\": \"Co-IP, in vitro prenylation assay, crystal structure of GGTase3-FBXL2-SKP1 complex, cell membrane localization assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation, in vitro reconstitution of enzymatic activity, and multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"31209342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PTAR1, together with the β-subunit of RabGGTase, constitutes GGTase-III, a novel prenyltransferase that geranylgeranylates the Golgi SNARE protein Ykt6 at Cys194 (the second prenylation, following prior farnesylation of Cys195 by FTase), generating a doubly prenylated Ykt6. In PTAR1-deficient cells, Ykt6 remains singly farnesylated, Golgi SNARE complex assembly is severely impaired, and the Golgi apparatus is structurally disorganized with delayed intra-Golgi protein trafficking. Crystal structure of GGTase-III in complex with Ykt6 provides the structural basis for double prenylation.\",\n      \"method\": \"Biotinylated geranylgeranyl analogue substrate identification, crystal structure of GGTase-III–Ykt6 complex, PTAR1 knockout cells with Golgi morphology and trafficking assays, SNARE complex assembly assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, reconstituted enzymatic activity with analogue labeling, and KO phenotypic validation using multiple orthogonal methods\",\n      \"pmids\": [\"32128853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In PTAR1 KO cells where Ykt6 is only singly farnesylated (lacking GGTase-III-mediated geranylgeranylation), lysosomal hydrolases (cathepsin D and β-hexosaminidase) are missorted at the trans-Golgi network and secreted extracellularly, hydrolase maturation is disturbed, and LC3B accumulates indicating defective autophagy/lysosomal degradation pathways. This establishes that doubly prenylated Ykt6 (requiring PTAR1/GGTase-III) is required for efficient sorting and trafficking of acid hydrolases from Golgi to lysosomes.\",\n      \"method\": \"PTAR1 knockout cells, secretion assays for cathepsin D and β-hexosaminidase, Western blotting for hydrolase maturation, LC3B immunoblotting\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, multiple substrates assessed, single lab\",\n      \"pmids\": [\"33035318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PTAR1 (α-subunit of GGTase-III) is expressed in human islets, mouse islets, and INS-1 832/13 pancreatic β-cells. siRNA-mediated knockdown of PTAR1 (~50% reduction) significantly attenuated glucose-stimulated insulin secretion (~60% reduction) and KCl-induced insulin secretion (~69% reduction), establishing a required role for GGTase-III-dependent signaling in insulin secretion.\",\n      \"method\": \"siRNA knockdown of PTAR1 in INS-1 832/13 cells, insulin ELISA, Western blotting\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, siRNA knockdown with functional readout but no direct molecular mechanism beyond Ykt6 substrate connection; partial mechanistic follow-up\",\n      \"pmids\": [\"40598917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Disruption of PTAR1 in haploid human cells led to resistance to Rift Valley fever virus infection and reduced heparan sulfate surface levels, consistent with PTAR1-deficient cells exhibiting altered Golgi complex morphology and glycosylation defects.\",\n      \"method\": \"Haploid genetic screen (insertional mutagenesis), flow cytometry for heparan sulfate levels, viral infection assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic screen with functional validation of Golgi/glycosylation phenotype, but mechanism is indirect (PTAR1 role in Golgi morphology/glycosylation inferred rather than directly dissected in this paper)\",\n      \"pmids\": [\"26581979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A biotinylated geranylgeranyl analogue was used to confirm Ykt6 (at Cys194) as the direct substrate of GGTase-III (PTAR1/RabGGTB). Sequential prenylation: FTase farnesylates Cys195 first, then GGTase-III geranylgeranylates Cys194, producing doubly prenylated Ykt6 essential for Golgi maintenance and autophagosome clearance.\",\n      \"method\": \"Biotin-labeled geranyl pyrophosphate analogue in vitro prenylation assay, site-specific cysteine identification\",\n      \"journal\": \"Methods in molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic assay with analogue substrate, single lab, methodological/confirmatory paper replicating prior findings\",\n      \"pmids\": [\"39806148\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTAR1 is the α-subunit of GGTase-III (also called GGTase3), a novel prenyltransferase complex formed with RabGGTB (the β-subunit of RabGGTase), which geranylgeranylates specific substrates including the Golgi SNARE Ykt6 (at Cys194, producing doubly prenylated Ykt6 required for Golgi organization, lysosomal hydrolase trafficking, and autophagy) and the ubiquitin ligase FBXL2 (via an extensive LRR–PTAR1 interface that confers substrate specificity distinct from GGTase1); loss of PTAR1 disrupts Golgi morphology, glycosylation, lysosomal sorting, and glucose-stimulated insulin secretion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PTAR1 is the α-subunit of GGTase-III (GGTase3), a prenyltransferase complex assembled with the catalytic β-subunit of RabGGTase (RabGGTB) that geranylgeranylates a small set of specific substrates and thereby governs Golgi organization and membrane trafficking [#0, #1]. One substrate is the Golgi SNARE Ykt6: GGTase-III geranylgeranylates Ykt6 at Cys194 following prior FTase-mediated farnesylation of Cys195, producing a doubly prenylated Ykt6, and crystal structures of the GGTase-III–Ykt6 complex define the structural basis for this second prenylation [#1, #5]. Loss of PTAR1 leaves Ykt6 only singly farnesylated, impairing Golgi SNARE complex assembly, disorganizing Golgi morphology, and delaying intra-Golgi trafficking [#1]; downstream, lysosomal hydrolases such as cathepsin D and β-hexosaminidase are missorted and secreted, hydrolase maturation is disturbed, and LC3B accumulates, marking defective autophagy/lysosomal degradation [#2]. The second characterized substrate is the F-box protein FBXL2: GGTase-III geranylgeranylates FBXL2 to drive its membrane localization, and the crystal structure of the GGTase3–FBXL2–SKP1 complex shows an extensive interface between FBXL2's leucine-rich-repeat domain and PTAR1 that dictates substrate specificity even though FBXL2's CaaX motif is predicted to be a GGTase1 substrate [#0]. Consistent with its role in Golgi/glycosylation homeostasis, PTAR1 disruption alters Golgi morphology, lowers cell-surface heparan sulfate, and confers resistance to Rift Valley fever virus [#4], and PTAR1 knockdown attenuates glucose- and KCl-stimulated insulin secretion in pancreatic β-cells [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2015,\n      \"claim\": \"Before any enzymatic role was known, an unbiased genetic screen implicated PTAR1 in Golgi function by linking its loss to glycosylation defects and viral resistance.\",\n      \"evidence\": \"Haploid insertional-mutagenesis screen with heparan sulfate flow cytometry and Rift Valley fever virus infection assays\",\n      \"pmids\": [\"26581979\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Golgi/glycosylation phenotype was inferred, not mechanistically dissected\", \"No enzymatic activity or substrate identified at this stage\", \"Connection to a prenyltransferase complex not yet established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established PTAR1 as the α-subunit of a novel prenyltransferase (GGTase3) by reconstituting its activity and solving its structure, answering what PTAR1 does biochemically and how it achieves substrate selectivity.\",\n      \"evidence\": \"Co-IP, in vitro prenylation assay, and crystal structure of the GGTase3–FBXL2–SKP1 complex with membrane-localization assays\",\n      \"pmids\": [\"31209342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FBXL2 ubiquitylation targets downstream of membrane localization not enumerated here\", \"Whether other LRR/CaaX proteins are substrates left open\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified the Golgi SNARE Ykt6 as a GGTase-III substrate and showed PTAR1 catalyzes a second prenylation (Cys194 geranylgeranylation after Cys195 farnesylation), explaining how PTAR1 controls Golgi architecture.\",\n      \"evidence\": \"Biotinylated geranylgeranyl analogue substrate ID, GGTase-III–Ykt6 crystal structure, and PTAR1 KO Golgi morphology, trafficking, and SNARE assembly assays\",\n      \"pmids\": [\"32128853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not extend to lysosomal/autophagy consequences\", \"Full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2 unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected PTAR1/double-prenylated Ykt6 to lysosomal homeostasis by showing acid hydrolases are missorted and autophagy is impaired in its absence.\",\n      \"evidence\": \"PTAR1 KO cells with cathepsin D and β-hexosaminidase secretion assays, hydrolase maturation Westerns, and LC3B immunoblotting\",\n      \"pmids\": [\"33035318\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; mechanism downstream of Ykt6 prenylation not fully resolved\", \"Direct causality versus general Golgi disruption not separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Confirmed Ykt6 Cys194 as the direct GGTase-III substrate and established the sequential FTase-then-GGTase-III prenylation order using analogue labeling.\",\n      \"evidence\": \"Biotin-labeled geranyl pyrophosphate analogue in vitro prenylation with site-specific cysteine identification\",\n      \"pmids\": [\"39806148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methodological/confirmatory; no new substrates\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended PTAR1 function to physiology by showing GGTase-III is required for glucose-stimulated insulin secretion in β-cells.\",\n      \"evidence\": \"siRNA knockdown of PTAR1 in INS-1 832/13 cells with insulin ELISA and Western blotting\",\n      \"pmids\": [\"40598917\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Partial (~50%) knockdown; no rescue\", \"Molecular mechanism linking GGTase-III to secretion beyond the Ykt6 connection not defined\", \"In vivo relevance untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2, and the precise mechanistic link between GGTase-III activity and insulin secretion, remain to be defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No comprehensive substrate census reported\", \"Mechanism connecting PTAR1 to β-cell secretion undefined\", \"No in vivo / disease-mutation evidence in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"GGTase-III (GGTase3)\"],\n    \"partners\": [\"RABGGTB\", \"YKT6\", \"FBXL2\", \"SKP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}